PT Prodia is one of the largest commercial laboratory groups in Indonesia with over 298 outlets providing a range of diagnostic services. In this Q&A with President Director of PT Prodia Dr Dewi Muliaty and Mr Poh Seng Lee, Director of the Diagnostics Division, PT Roche Indonesia, they sit down to discuss the importance of maintaining high-quality standards in the laboratory, the approach needed to serve the diverse landscape of Indonesia, and how digitalisation can bridge the gap between labs and customers. https://lnkd.in/guhguZuV
Roche Diagnostics Asia Pacific
Biotechnology Research
Singapore, Singapore 8,994 followers
Doing now what patients need next.
About us
Performed on blood, tissue or other patient samples, in vitro diagnostics are a critical source of objective information for improved disease management and patient care.
- Website
-
https://www.roche.com/about/business/diagnostics.htm
External link for Roche Diagnostics Asia Pacific
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Singapore, Singapore
Updates
-
Discover the latest trends and innovations in healthcare technology and exchange ideas and insights that will shape tomorrow’s healthcare. Join Roche at #HIMSS24APAC Meet our experts to learn about the latest innovations in lab diagnostics and how they help to revolutionize patient care. Learn more: https://lnkd.in/gYFHXauB Seoul, Korea | Booth H17 | 2-4 Oct, 2024 #digitalhealth #healthcaretransformation #digitaltransformation #RocheDiagnostics
-
Catch up with: Roche at Hospital Management Asia 2024 Here are 3 key takeaways from our 'Tomorrow's Health Today: Exploring Digital Transformation in Healthcare' session last week: - Adopting digital solutions begins with clear principles and collaboration supported by a team culture fostering innovation. - Digital enhances patient care through multidisciplinary collaboration, operational excellence, and advanced medical decision-making. - Hospital leaders must navigate the AI era with an open mindset to explore the positive impact of AI’s clinical use. The audience was eager to delve into the speaker's experiences with AI and their strategies for navigating the challenges of digital tools during the Q&A session. Thank you to our speakers for their insightful session, and to everyone who joined us and visited the Roche booth. Your commitment to advancing patient care through digital transformation was truly inspiring! Ralf Maier-Reinhardt, Assoc. Prof. Dr. Patravoot Vatanasapt, Dr. Miswar Fattah, Chris Chiam & Dr. Kiang Wei L. #RocheatHMA2024 #digitalhealth #healthcaretransformation #digitaltransformation #RocheDiagnostics
-
+1
-
The Lab Insights team had a chat with Professor Aw Tar Choon on better understanding HbA1c as a biomarker. In Part 2 of this Q&A, Prof Aw talks more about the implementation of this biomarker in the laboratory, discussing workflows, result interpretation and how best to optimise your lab for it. Read on to find out more. https://lnkd.in/gXU2DB8T
-
In diabetes management, HbA1c is a biomarker that can consistently reflect glycemic control in an individual. To know more about how HbA1c testing is used, Professor Aw Tar Choon of Changi General Hospital shares with us the role of this biomarker in diabetes management in Part 1 of this series. Read on to find out more. https://lnkd.in/gwv3tSzK
-
South Africa is one of the leading countries in the world when it comes to tuberculosis (TB) elimination. The Lab Insights team recently had a chance to talk to Ms Anura David, Senior Medical Scientist at the Wits Diagnostic Innovation Hub in South Africa, who has over a decade's worth of experience in the realm of TB research. Ms David discusses the unique TB infrastructure in South Africa, and what it takes to overcome the last hurdles in TB elimination. https://lnkd.in/e-eMqp3b
-
In clinical labs, maintaining accuracy and reliability of results generated remains a top priority. To maintain this rigorous standard, labs routinely conduct quality control checks. In recent years, there has been a growing demand for third-party quality control materials that come with a range of benefits. To learn more about the benefits of third-party quality controls, click on the link below to find out more. https://lnkd.in/gtGFWZps
-
We're thrilled to celebrate the expansion of our Suzhou site, Roche Diagnostics' first manufacturing and R&D hub in Asia Pacific. Established in 2015, this expansion will enhance our production capacity, accelerate R&D, and ensure the timely delivery of crucial diagnostics solutions, benefiting patients across China and the broader Asia Pacific region. Thank you to the Jiangsu government for our continued partnership and collaboration. It's our privilege to work with you towards our collective mission to advance healthcare for patients in China and beyond. Together, we continue to build capabilities that support patient needs today and in the future. #Roche #HealthcareInnovation #AsiaPacific #Diagnostics #PatientCare
-
AOGIN 2024 was held in Seoul, South Korea, with the theme "Empowering Women, Together against Cervical Cancer". This bi-annual conference aims to share updates in policies and guidelines, updates in vaccination and tests, as well as the latest treatment methods and programmes in several countries. Click the link below to read about the key takeaways from the conference. https://lnkd.in/g92jMKtY
Advancing women’s health: key takeaways from AOGIN 2024 | Lab Insights
labinsights.com
-
🌍 At Roche Diagnostics, our commitment goes beyond innovation—we believe in making a tangible difference in people’s lives. As a healthcare company, it's our responsibility to highlight the importance of early testing and work with our communities to remove barriers that prevent people from accessing essential health checks. We're aware of the impact culture and stigmas have on preventing people from accessing healthcare. We're working towards a world where everyone has the opportunity to take control of their health. With our 'Everyone Deserves to Get Tested' campaign, we're challenging the status quo, hoping to create a conversation on how healthcare is a right for everyone. Check out this insightful article to learn more about our campaign and how we aim to drive positive change in communities across Asia Pacific. Together, we can advance health equity and improve lives. 💪🔬 Read more here: https://lnkd.in/gciM7ncg #RocheDiagnostics #HealthEquity #SocialResponsibility #Advocacy #HealthcareInnovation
Blending advocacy and social responsibility: Behind Roche Diagnostics’ ‘Everyone Deserves to Get Tested’ campaign rollout - MARKETECH APAC
https://marketech-apac.com